The historical rank and industry rank for Vaidyane Ayurved Laboratories's Days Payable or its related term are showing as below:
NSE:MADHAVBAUG'
s Days Payable Range Over the Past 10 Years
Min: 109.17 Med: 127.71 Max: 163.23
Current: 120.05
During the past 8 years, Vaidyane Ayurved Laboratories's highest Days Payable was 163.23. The lowest was 109.17. And the median was 127.71.
NSE:MADHAVBAUG's Days Payable is ranked better than 65.91% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs NSE:MADHAVBAUG: 120.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MADHAVBAUG vs ZTS, UTHR: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaidyane Ayurved Laboratories Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where Vaidyane Ayurved Laboratories's Days Payable falls into.
Vaidyane Ayurved Laboratories Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Days Payable of 101.35 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vaidyane Ayurved Laboratories and its competitors. This is 21% below median its historical median of 127.71. Over the past decade, Vaidyane Ayurved Laboratories' Days Payable has ranged from 109.17 to 163.23. According to the industry distribution chart, Vaidyane Ayurved Laboratories ranks #316 out of 927 companies in the Drug Manufacturers industry, placing it in the top 34.1%.
Is Vaidyane Ayurved Laboratories' Days Payable too high?
Vaidyane Ayurved Laboratories' current Days Payable of 101.35 is 21% below median its 10-year median of 127.71. Over the past 10 years, this metric has ranged from a low of 109.17 to a high of 163.23. The Drug Manufacturers industry median Days Payable is 90.38. Vaidyane Ayurved Laboratories' value of 101.35 is 12.1% above this industry median. Based on the distribution chart, Vaidyane Ayurved Laboratories ranks #316 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vaidyane Ayurved Laboratories ranks #316 out of 927 companies for Days Payable. This puts Vaidyane Ayurved Laboratories in the upper half of its industry. The industry median Days Payable is 90.38. Vaidyane Ayurved Laboratories' value of 101.35 is 12.1% above this benchmark. Historically, Vaidyane Ayurved Laboratories' own Days Payable has ranged from 109.17 to 163.23 over the past decade. While the company's 10-year median is 127.71 vs. the industry median of 90.38, Vaidyane Ayurved Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaidyane Ayurved Laboratories's current Days Payable of 101.35 is 12.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vaidyane Ayurved Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaidyane Ayurved Laboratories's current Days Payable is 101.35, which is 21% below median its own 10-year median of 127.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.12, compared to a current price of ₹183.90 — trading 19.4% below its estimated fair value. The current Days Payable is 101.35, which is 21% below median its 10-year median of 127.71 and 12.1% above the Drug Manufacturers industry median of 90.38. Vaidyane Ayurved Laboratories' overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Days Payable is 101.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued.
The current stock price of ₹183.90 is trading 19.4% below its estimated GF Value™ of ₹228.12.
GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:MADHAVBAUG:
Days Payable: 101.35 (21% below median its 10-year median of 127.71)
GF Value™: ₹228.12 vs. price of ₹183.90 (19.4% below fair value)
Industry Position: 12.1% above the Drug Manufacturers median (#316 of 927)
No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
84GF Score
Get the complete analysis for NSE:MADHAVBAUG
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MADHAVBAUG has been successfully added to your 
